1-20 of 54
Authors: M. Augustin
Journal Article
Association of sex and systemic therapy treatment outcomes in psoriasis: a two‐country, multicentre, prospective, noninterventional registry study Get access
British Journal of Dermatology, Volume 185, Issue 6, 1 December 2021, Pages 1160–1168, https://doi.org/10.1111/bjd.20387
Published: 01 December 2021
Journal Article
The value of subcutaneous vs. oral methotrexate: real‐world data from the German psoriasis registry PsoBest
British Journal of Dermatology, Volume 184, Issue 4, 1 April 2021, Pages 765–767, https://doi.org/10.1111/bjd.19690
Published: 01 April 2021
Journal Article
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 548–550, https://doi.org/10.1111/bjd.19558
Published: 01 March 2021
Journal Article
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study Get access
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 425–436, https://doi.org/10.1111/bjd.19262
Published: 01 March 2021
Includes: Multimedia
Journal Article
Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany
British Journal of Dermatology, Volume 183, Issue 2, 1 August 2020, Pages 382–384, https://doi.org/10.1111/bjd.18958
Published: 01 August 2020
Journal Article
An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12 Get access
British Journal of Dermatology, Volume 183, Issue 1, 1 July 2020, Pages 52–59, https://doi.org/10.1111/bjd.18550
Published: 01 July 2020
Journal Article
A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Pages 869–879, https://doi.org/10.1111/bjd.18384
Published: 01 April 2020
Journal Article
A trial to compare the biologic drug ixekizumab with two other treatments for psoraisis, fumaric acid esters and methotrexate Get access
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Page e138, https://doi.org/10.1111/bjd.18905
Published: 01 April 2020
Journal Article
比较生物制剂依奇珠单抗与其他两种治疗银屑病的药物富马酸酯和甲氨蝶呤的试验 Get access
British Journal of Dermatology, Volume 182, Issue 4, 1 April 2020, Page e148, https://doi.org/10.1111/bjd.18915
Published: 01 April 2020
Journal Article
The efficacy of secukinumab with continued use in the treatment of psoriasis Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e22, https://doi.org/10.1111/bjd.18653
Published: 01 January 2020
Journal Article
苏金单抗持续用于治疗银屑病的疗效 Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e39, https://doi.org/10.1111/bjd.18670
Published: 01 January 2020
Journal Article
Continued treatment with secukinumab is associated with high retention or regain of response Get access
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Pages 67–75, https://doi.org/10.1111/bjd.17991
Published: 01 January 2020
Includes: Multimedia
Journal Article
Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 976–982, https://doi.org/10.1111/bjd.17832
Published: 01 November 2019
Journal Article
Plaque psoriasis in patients with palmoplantar pustulosis Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Page e129, https://doi.org/10.1111/bjd.18497
Published: 01 November 2019
Journal Article
Effects of psychosocial interventions on patient‐reported outcomes in patients with psoriasis: a systematic review and meta‐analysis Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 939–945, https://doi.org/10.1111/bjd.17272
Published: 01 November 2019
Journal Article
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Pages 954–966, https://doi.org/10.1111/bjd.17351
Published: 01 November 2019
Journal Article
掌跖脓疱病患者中的斑片状银屑病 Get access
British Journal of Dermatology, Volume 181, Issue 5, 1 November 2019, Page e141, https://doi.org/10.1111/bjd.18509
Published: 01 November 2019
Journal Article
脂溢性皮炎的流行病学特征 Get access
British Journal of Dermatology, Volume 181, Issue 4, 1 October 2019, Page e103, https://doi.org/10.1111/bjd.18399
Published: 01 October 2019
Journal Article
Epidemiology of seborrheic dermatitis Get access
British Journal of Dermatology, Volume 181, Issue 4, 1 October 2019, Page e92, https://doi.org/10.1111/bjd.18388
Published: 01 October 2019
Journal Article
Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population‐based study in 161 269 employees Get access
British Journal of Dermatology, Volume 181, Issue 4, 1 October 2019, Pages 743–748, https://doi.org/10.1111/bjd.17826
Published: 01 October 2019
